Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-07 |
mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-07 |
mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-06 |
mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-06 |
mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-06 |
mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |